MM Treatment: Clinical Advice on the Care of Patients Receiving Talquetamab

April 11, 2024

By Donna Catamero, ANP-BC, OCN, CCRC
Beth Faiman, PhD, MSN, APN-BC

Opinion

Video

Tiffany Richards, PhD, ANP-BC, and the rest of the panel offer clinical advice on the care of patients with multiple myeloma who are receiving talquetamab.

EP: 1.Patient Scenario: A 63-Year-Old Man with Multiple Myeloma

EP: 2.Resources for Educating Patients with Myeloma

EP: 3.Patient Scenario Cont’d: Treatment in Late-Line Relapsed MM

EP: 4.Treatment Sequencing and the Role of Talquetamab in MM

EP: 5.Educating Patients on Adverse Effects Related to Talquetamab in MM

EP: 6.Managing Talquetamab-Associated Toxicities in Patients with MM

EP: 7.The Role of a GPRC5D-Targeting Bispecific in Relapsed/Refractory MM

Now Viewing

EP: 8.MM Treatment: Clinical Advice on the Care of Patients Receiving Talquetamab

EP: 9.Key Takeaways on Evolving Treatment Landscape in Multiple Myeloma

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!